Barth Syndrome Families Share Stories At FDA Hearing With Help From Believe Limited

This fall, we teamed up with the Barth Syndrome Foundation (BSF) to create a series of impactful patient testimonial videos, supported by Stealth BioTherapeutics. These videos aimed to raise awareness about Barth syndrome, an ultra-rare genetic disorder, while encouraging donations to support ongoing research and advocacy efforts.

On October 10, 2024, families affected by Barth syndrome gathered in Washington, D.C. to share their personal stories with the FDA, emphasizing the critical need for elamipretide, a potential first-of-its-kind therapy for this life-threatening condition. Their stories highlighted the real-world impact of living with Barth syndrome and the hope that new treatments could bring.

We’re honored to have played a role in amplifying these voices and supporting BSF’s advocacy work. To learn more about Barth syndrome and how you can help, visit Barth Syndrome Foundations’s website.

About Believe Limited

Believe Limited is committed to producing content that makes a difference. From groundbreaking series like Beyond Our Blood to award-winning podcasts, we focus on creating meaningful media that addresses critical social issues and celebrates the strength of the human experience.

Next
Next

Celebrating Rare Disease Week: How Believe Limited Connects with Patients